Skip to main content Skip to section navigation Skip to footer
Vivani Medical, Inc.
  • Investors
  • IR Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Our Company
    • Overview
    • Executive Leadership
    • Code of Ethics
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Annual Reports & Proxy Statements
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
    • Privacy

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • In the News
  • IR Calendar
  • Presentations
  • Email Alerts
      Aug 28, 2024 7:10pm EDT

      Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

      Aug 13, 2024 4:05pm EDT

      Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

      Jul 11, 2024 8:00am EDT

      Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

      Jun 13, 2024 8:00am EDT

      Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

      May 28, 2024 8:00am EDT

      Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

      May 13, 2024 4:45pm EDT

      Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

      May 09, 2024 8:00am EDT

      Vivani Medical to Present at TIDES Conference 2024

      Mar 26, 2024 8:30am EDT

      Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

      Mar 06, 2024 8:00am EST

      Vivani Medical Appoints Daniel Bradbury to its Board of Directors

      Mar 01, 2024 7:49am EST

      Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

      • Previous Pagearrow_back
      • Page 1
      • Page 2
      • Page 3
      • Page 4
      • Page 5
      • Page 6
      • Page 7
      • Page 8
      • Page 9
      • Page 10
      • …
      • Page 20
      • Next Pagearrow_forward
      rss_feed News RSS
      • Email Alerts
      • Contacts
      • RSS News Feed
      ©2025 Vivani Medical, Inc. All Rights Reserved.
      Privacy Policy Disclaimer Sitemap